Browse by Audience
Skip to content
Papers of the Week
Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases.
Authors
Cho J, Jo H, Park J, Lee K, Lee H, Kim S, Son Y, Oh J, Jeong J, Lee S, Oh J, Cho H, Yang JM, Woo HG, Yon DK, Smith LAbstract
Migraine is a major cause of population ill health, with an estimated global prevalence of approximately 14-15%. However, given the limited research on the associations between specific migraine medications and adverse cerebrovascular events, this study aimed to investigate these relationships and their impact on cerebrovascular risk.